SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-082342
Filing Date
2023-07-19
Accepted
2023-07-19 16:05:15
Documents
17
Period of Report
2023-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2321519d1_8k.htm   iXBRL 8-K 31779
2 EXHIBIT 4.1 tm2321519d1_ex4-1.htm EX-4.1 103261
3 EXHIBIT 5.1 tm2321519d1_ex5-1.htm EX-5.1 9884
4 EXHIBIT 10.1 tm2321519d1_ex10-1.htm EX-10.1 223585
5 EXHIBIT 10.2 tm2321519d1_ex10-2.htm EX-10.2 79819
6 EXHIBIT 99.1 tm2321519d1_ex99-1.htm EX-99.1 10007
  Complete submission text file 0001104659-23-082342.txt   740946

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20230717.xsd EX-101.SCH 3036
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20230717_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20230717_pre.xml EX-101.PRE 22373
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2321519d1_8k_htm.xml XML 3323
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 231096743
SIC: 2836 Biological Products, (No Diagnostic Substances)